Hutner Capital Management Inc Abbott Laboratories Transaction History

Hutner Capital Management Inc

  • $201 Million
  • Q3 2024

A detailed history of Hutner Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Hutner Capital Management Inc holds 41,950 shares of ABT stock, worth $4.96 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares
41,950
Previous 42,001 0.12%
Holding current value
$4.96 Million
Previous $4.36 Million 9.58%
% of portfolio
2.38%
Previous 2.39%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$100.07 - $118.13 $5,103 - $6,024
-51 Reduced 0.12%
41,950 $4.78 Million
Q2 2024

Aug 13, 2024
SELL
$100.73 - $112.44 $112,817 - $125,932
-1,120 Reduced 2.6%
42,001 $4.36 Million
Q1 2024

May 10, 2024
SELL
$109.52 - $120.96 $9,418 - $10,402
-86 Reduced 0.2%
43,121 $4.9 Million
Q4 2023

Feb 14, 2024
SELL
$90.19 - $110.4 $13,438 - $16,449
-149 Reduced 0.34%
43,207 $4.76 Million
Q3 2023

Nov 14, 2023
SELL
$95.53 - $114.62 $43,943 - $52,725
-460 Reduced 1.05%
43,356 $4.2 Million
Q2 2023

Aug 14, 2023
SELL
$100.78 - $112.29 $98,865 - $110,156
-981 Reduced 2.19%
43,816 $4.78 Million
Q1 2023

May 15, 2023
SELL
$96.86 - $114.01 $968 - $1,140
-10 Reduced 0.02%
44,797 $4.54 Million
Q4 2022

Feb 14, 2023
BUY
$95.06 - $111.52 $156,088 - $183,115
1,642 Added 3.8%
44,807 $4.92 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $119,111 - $137,908
1,231 Added 2.94%
43,165 $4.18 Million
Q2 2022

Aug 11, 2022
BUY
$102.07 - $123.37 $14,085 - $17,025
138 Added 0.33%
41,934 $4.56 Million
Q1 2022

May 13, 2022
SELL
$114.02 - $139.04 $15,962 - $19,465
-140 Reduced 0.33%
41,796 $4.95 Million
Q4 2021

Feb 11, 2022
SELL
$115.53 - $141.46 $1,964 - $2,404
-17 Reduced 0.04%
41,936 $5.9 Million
Q3 2021

Nov 12, 2021
SELL
$116.66 - $129.06 $22,282 - $24,650
-191 Reduced 0.45%
41,953 $4.96 Million
Q2 2021

Aug 13, 2021
SELL
$105.79 - $124.53 $311,445 - $366,616
-2,944 Reduced 6.53%
42,144 $4.89 Million
Q1 2021

May 18, 2021
BUY
$108.84 - $128.23 $79,779 - $93,992
733 Added 1.65%
45,088 $5.4 Million
Q4 2020

Feb 16, 2021
SELL
$105.0 - $114.42 $6,195 - $6,750
-59 Reduced 0.13%
44,355 $4.86 Million
Q3 2020

Nov 13, 2020
SELL
$91.64 - $111.29 $44,353 - $53,864
-484 Reduced 1.08%
44,414 $4.83 Million
Q2 2020

Aug 14, 2020
SELL
$76.57 - $98.0 $6,585 - $8,428
-86 Reduced 0.19%
44,898 $4.11 Million
Q1 2020

May 13, 2020
SELL
$62.82 - $91.86 $138,580 - $202,643
-2,206 Reduced 4.67%
44,984 $3.55 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $65,881 - $71,435
-805 Reduced 1.68%
47,190 $3.95 Million
Q2 2019

Aug 07, 2019
BUY
$72.88 - $85.0 $1,457 - $1,700
20 Added 0.04%
47,995 $4.04 Million
Q1 2019

May 10, 2019
SELL
$66.22 - $80.06 $96,019 - $116,087
-1,450 Reduced 2.93%
47,975 $3.84 Million
Q4 2018

Feb 12, 2019
BUY
$65.56 - $74.27 $7,539 - $8,541
115 Added 0.23%
49,425 $3.58 Million
Q3 2018

Nov 02, 2018
SELL
$60.81 - $73.36 $5,412 - $6,529
-89 Reduced 0.18%
49,310 $3.62 Million
Q2 2018

Jul 06, 2018
BUY
$57.57 - $63.54 $20,725 - $22,874
360 Added 0.73%
49,399 $3.01 Million
Q1 2018

Apr 06, 2018
SELL
$56.27 - $63.62 $8,721 - $9,861
-155 Reduced 0.32%
49,039 $2.94 Million
Q4 2017

Feb 01, 2018
BUY
$53.68 - $57.47 $90,504 - $96,894
1,686 Added 3.55%
49,194 $2.81 Million
Q3 2017

Oct 30, 2017
BUY
$48.06 - $53.64 $2.28 Million - $2.55 Million
47,508
47,508 $2.54 Million

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hutner Capital Management Inc Portfolio

Follow Hutner Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutner Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hutner Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email